Skip to main content
Tech.euFundingExplorerBeta

EVANIUM

Regensburg-based life-science company developing ingredients based on its IP-protected drug delivery technology OPTISOLV®

Total raised
€2.2M
€2,200,000
Funding rounds
1
Investors
3
distinct backers
Active since
2026-04
latest 2026-04

Funding by year

EUR raised per year · 2026 YTD

Signals

High confidence
Raise-next likelihood28
base rate 44% for Seed
  • Raised very recently
  • Low backer re-investment

Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2026-04-15Seed€2.2MAngel Investors,Feast Ventures,FoodLabsView deal →

Related news

Similar companies

same sector or country